Corries welcome Lung cancer NICE decision
Corries Solicitors Ltd welcome the decision by the National Institute for Health and Care Excellence (NICE) to allow the use by the NHS of the drug Tagrisso (osmertinib) for non small cell lung cancer patients.
The drug has been shown to be effective in controlling the progression of tumours in the short term. Following an agreement with the drug company a tariff is agreed to allow the drug to be paid using the Cancer Drugs Fund.
Corries Asbestos specialist solicitor, Charlie Bradley commented:
“This is good news for those suffering non small cell lung cancer who are suitable for the treatment.
This gives optimism at a time when more cancer beating drugs become available to help those suffering”
If you, a family member or friend have been affected due to lung cancer then telephone Corries Asbestos Team on Freephone 0800 083 7839